| |
Time |
Who |
Title |
Talk Title |
| Introductions |
9:00-9:10 |
Kathy Giacomini |
Dean, School of Pharmacy, UCSF |
|
| |
9:10-9:15 |
Nadav Ahituv |
Director, Institute for Human Genetics, UCSF |
|
| Gene Therapy |
9:15-9:35 |
Christof Fellmann |
Head of CRISPR-X, Executive Director, CRISPR Therapeutics |
Translating gene editing to the clinic |
| |
9:35-9:55 |
David Schaffer |
Professor, Director of QB3, Director of Bakar Labs, UC Berkeley |
Directed Evolution of Novel Adeno-Associated Viral Vectors for Clinical Gene Therapy |
| |
9:55-10:25 |
Francine Gregoire |
Chief Scientific Officer, Addition Therapeutics |
PRINTing the Future: How Retrotransposons Will Transform Genetic Medicine |
| |
10:25-10:45 |
Kyle Cromer |
Assistant Professor, Surgery, UCSF |
Using human genetics to increase production of clinically relevant cell types |
| |
10:45-11:15 |
Panel Discussion |
|
|
| Refreshment Break |
11:15-11:45 |
|
|
|
| Keynote Speaker |
11:45-12:30 |
Emil Kakkis |
Founder, President and Chief Executive Officer, Ultragenyx |
The development of treatments for rare diseases: the impact of genetics technologies to open the path to first-ever treatments |
| Lunch & Career Panel |
12:30-1:45 |
| Christina Fan |
| Francine Gregoire |
| Emil Kakkis |
| David Kelley |
|
| Co-Founder and Chief Technology Officer, Curio Bioscience |
| Chief Scientific Officer, Addition Therapeutics |
| Founder, President and Chief Executive Officer, Ultragenyx |
| Principal Investigator, Calico Life Sciences |
|
The career panel will be a round table discussion. Nick Page, PhD student, will lead the discussion with a few questions to get the ball rolling and from there we can take questions from other PhD students and postdocs in the audience. Come learn more about exciting and impactful career paths in the biotech industry. To join simply take your lunch to room GH-N114 (on the first floor of the Genentech building).
|
| AI |
1:45-2:05 |
Andrew Carroll |
Product Lead Genomics in Google Research |
Deep Learning for Clinical Genetics and Cohort Genomics |
| |
2:05-2:25 |
David Kelley |
Principal Investigator, Calico Life Sciences |
Predicting RNA-seq coverage from DNA sequence as a unifying model of gene regulation |
| |
2:25-2:45 |
Danny Wells |
Founder - Santa Ana Bio, Immunai |
Lessons from the front lines of building platform biotherapeutics companies |
| |
2:45-3:05 |
Tony Capra |
Professor, Epidemiology & Biostatistics and Bakar Computational Health Sciences Institute, UCSF
|
AI as a time machine: predicting ancient and future phenotypes with sequence-based machine learning |
| |
3:05-3:25 |
Panel Discussion |
|
|
| Refreshment Break |
3:25-3:55 |
|
|
|
|
Genomic Technologies
|
3:55-4:15 |
Christina Fan |
Co-Founder and Chief Technology Officer, Curio Bioscience |
Bringing spatial context to single-cell multiomic studies |
| |
4:15-4:35 |
Andrew Farmer |
Chief Scientific Officer and Head of Research & Development, Takara Bio USA |
Driving biomarker discovery with high-throughput single-cell genome and transcriptome profiling |
| |
4:35-4:55 |
Wenjun Ouyang |
Senior VP, Inflammation and Fibrosis, Data Science, Discovery Science & Technology, Gilead |
Exploring Treg dynamics and identifying CCR8 as a therapeutic target by scRNAseq in human cancers and preclinical models |
| |
4:55-5:15 |
Yin Shen |
Professor, Neurology, UCSF |
Characterizing Human Genome Function at Base Pair Resolution |
| |
5:15-5:45 |
Panel Discussion |
|
|
| Reception |
5:45-6 |
|
|
|